Galera Therapeutics (GRTX)
US Market

Galera Therapeutics (GRTX) Financial Statements


Galera Therapeutics Financial Overview

Galera Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.997; its P/E ratio is -0.19; Galera Therapeutics is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -4.38M$ -4.88M$ -12.99M$ -16.31M$ -13.49M
EBITDA$ -4.37M$ -4.67M$ -12.97M$ -16.30M$ -13.47M
Net Income Common Stockholders$ -4.38M$ -5.59M$ -10.90M$ -20.71M$ -17.71M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 13.47M$ 18.26M$ 28.36M$ 38.76M$ 47.75M
Total Assets$ 19.65M$ 26.14M$ 37.78M$ 48.28M$ 59.71M
Total Debt$ 1.21M$ 1.25M$ 1.29M$ 1.32M$ 0.00
Net Debt$ -12.25M$ -17.01M$ -27.08M$ -37.43M$ -47.75M
Total Liabilities$ 154.34M$ 157.33M$ 164.33M$ 163.28M$ 157.33M
Stockholders Equity$ -134.69M$ -131.19M$ -126.55M$ -114.95M$ -97.58M
Cash Flow-
Free Cash Flow$ -4.79M$ -9.92M$ -12.52M$ -10.80M$ -11.67M
Operating Cash Flow$ -4.79M$ -9.91M$ -12.52M$ -10.75M$ -11.67M
Investing Cash Flow-$ 3.98M$ 10.46M$ 7.55M$ 5.30M
Financing Cash Flow-$ -232.00K$ 2.13M$ 1.81M$ 27.78M
Currency in USD

Galera Therapeutics Earnings and Revenue History

Galera Therapeutics Debt to Assets

Galera Therapeutics Cash Flow

Galera Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis